SHH and its target gene GLI1 were also shown to be overexpressed in GHomas, ACTHomas, and prolactinomas, further supporting that excess SHH signaling is involved in the development/maintenance of hormone-producing PAs. This evidence concerns the gene GLI1 and ACTH-producing pituitary gland adenoma.